NovaBridge Biosciences
NovaBridge Biosciences (NBP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NBP · as of Jun 9, 2026
Key Statistics
Explore NovaBridge Biosciences Data
nbp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 100.0%
The NBP analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +476.92% upside from the current price of $1.56.
Competitors & Peers
nbp competitorsNBP
ALT
ANNX
AURA
DMAC
DRTSStock Performance
Full HistoryAbout NovaBridge Biosciences
NovaBridge Biosciences a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several signifi…
what is novabridge biosciences · nbp stock overview · novabridge biosciences company profile · who is novabridge biosciences ceo · nbp NASDAQ · novabridge biosciences headquarters · novabridge biosciences business segments
About Stock Overview & Key Data
NovaBridge Biosciences (NBP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 17, 2020. As of the latest trading session, NBP stock price is $1.56, with a market capitalization of $179.8M. The stock has returned -44.29% over the past 12 months and -60.80% year-to-date.
According to 11 Wall Street analysts, the consensus rating for NovaBridge Biosciences stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2025, NovaBridge Biosciences reported revenue of — and net income of -$6.6M. For detailed data — including NovaBridge Biosciences revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NovaBridge Biosciences (NBP) stock price is $1.56. The stock is traded on NASDAQ under the ticker symbol NBP. The 52-week range is $1.53 – $6.79.